Claude

IntuitionLabs is now a member of the Claude Partner Network – AI training and upskilling with Claude for pharma and biotech. Book a call.

IntuitionLabs
Back to Articles
IntuitionLabs

ux-design · hcp-engagement

UX Best Practices for HCP Engagement Platforms

May 8, 2025
Updated July 21, 2026
25 min read

Evidence-based UX strategies for digital HCP engagement platforms in pharma: trends, challenges, best practices, and compliance for IT teams.

UX Best Practices for HCP Engagement Platforms
Summary
  1. 01Over 25% of US physicians now prefer more digital and less face-to-face pharma engagement, and 84% want to maintain or increase virtual interactions.
  2. 02Omnichannel engagement generates up to 30% more engagement than single-channel campaigns, per McKinsey research.
  3. 03HHS Section 504 requires HCP platforms to meet WCAG 2.1 AA accessibility standards by May 11, 2027 for organizations with 15+ employees and May 10, 2028 for smaller ones.
  4. 04Healthcare data breaches now average $7.42 million per incident, underscoring the need for robust security and compliance by design.
  5. 05Agentic AI systems are projected to deliver 30-45% productivity gains and 75-85% automation of pharma-HCP workflows within five years.
  6. 06Over 70% of physicians use smartphones or tablets for professional purposes, making mobile-first, responsive design essential.

[Revised July 10, 2026]

For a step-by-step guide to planning and building a custom HCP engagement portal, see our companion article: Building a Custom HCP Engagement Portal.

As Think Company notes, UX design is now considered essential, not optional, for a successful pharma marketing strategy. This report reviews current trends, challenges, and evidence-based UX strategies for digital platforms serving healthcare professionals (HCPs) in the US pharmaceutical industry. It covers HCP engagement trends, common UX challenges in HCP portals/CRMs/education platforms, best practices (personalization, responsiveness, information architecture, privacy/security, accessibility), the role of data and behavioral insights in design, illustrative case studies, and industry/regulatory considerations. All guidance is grounded in industry sources and research to aid IT professionals in pharma.

02

UX Challenges in HCP-Focused Platforms

Pharma IT teams face several common UX pitfalls when building portals, CRMs, and education platforms for HCPs:

  • Complex navigation and information overload: HCPs are busy and information-hungry. Overly complex menus or excessive content can frustrate them. One industry blog warns against a "labyrinthine maze of menus" and "overwhelming users with excessive content". Poor site architecture often leaves HCPs unable to find needed resources, reducing platform utility (e.g., one pharma portal lacked search and had outdated info).

  • Lack of user-centric design: Many platforms fail to account for HCP workflows and contexts. If the system doesn't match their needs (e.g. by specialty or practice size), HCPs disengage. As one expert notes, HCP portals must be "tailored to their needs" and built on insights from usability studies. Ignoring user research leads to generic, "one-size-fits-all" experiences that feel irrelevant.

  • Limited mobile optimization: HCPs often browse on mobile devices between patient visits. A common mistake is not making the portal fully responsive. "Ignoring mobile optimization can be a grave error" because HCPs are "constantly on the move". Without mobile-friendly design (or a progressive web app version for offline access), usage drops.

  • Value exchange and gated content: HCPs expect clear value from logging into a portal. If content is mostly promotional or locked behind excessive authentication, they may lose interest. Curate up-to-date research, tools, and CME to create a clear value exchange and encourage return visits. Conversely, hiding content behind onerous logins can deter usage.

  • Regulatory and privacy friction: HIPAA applies when a platform operator is a covered entity or business associate and the platform creates, receives, maintains, or transmits electronic protected health information (ePHI). Other platforms may still be subject to applicable privacy, security, and promotional-content requirements, which vary by jurisdiction and use case. Excessive security steps (e.g. cumbersome authentication) or unclear privacy policies can hamper adoption, while a breach or noncompliance can erode trust.

  • Lack of personalization: HCPs expect experiences tailored to their specialty, geography, and preferences. Generic "cookie-cutter" interfaces fail to engage them. For example, an HCP portal that shows irrelevant content (e.g. a cardiologist seeing dermatology ads) will frustrate users.

  • Content maintenance issues: Even a well-designed platform flounders if content is outdated or poorly managed. Multi-regional portals can struggle with localized content coherence. One case noted that poor site architecture made it hard to update information across local sites.

  • Accessibility gaps: Although HCPs are not patients, accessibility (e.g. for color vision, different languages) still matters, especially for global portals or older users. However, this is often overlooked in enterprise UX.

In summary, HCP platforms can stumble on both functional (e.g. search, mobile) and strategic (value, personalization) UX fronts. The next section outlines best practices to overcome these hurdles.

03

UX Best Practices for Engaging HCPs

Based on industry research and case examples, the following design principles are recommended for HCP engagement platforms:

1. AI-Powered Personalization and User-Centric Content

  • Tailor content to HCP needs: Use segmentation by specialty, role, geography, and past behavior to deliver relevant information. Personalization can involve custom dashboards, specialty-specific news feeds, or patient-case calculators. HCP AI adoption has surged from ~40% in 2023 to 66% in 2024, making AI-assisted personalization increasingly expected. Allow HCPs to customize their view (bookmarks, saved searches) to give them a sense of ownership.

  • AI-driven adaptive personalization: Modern platforms leverage AI to analyze HCP behavior in real-time, adapting content, timing, and channel to fit each HCP's unique preferences. According to Thoughtworks, leading organizations use "Next Best Action" (NBA) engines grounded in robust data platforms that integrate diverse data sources, providing representatives with deep insights into HCP preferences and recommending the most effective actions for each HCP. AI can summarize lengthy clinical documents into digestible insights, automate follow-up triggers, and power virtual moderator assistants.

  • 2026-2027 outlook:Doceree's 360 Report forecasts that by 2026-27, agentic AI systems will enable pharma brands to deliver credible, context-aware intelligence at unprecedented scale. Industry projections suggest 30-45% productivity gains and 75-85% automation of current pharma-HCP workflows within five years. By 2027, personalization will shift from demographic segments to real-time context recognition—enabling AI to continuously understand what an HCP is doing in the moment and adapt dynamically.

  • User research and feedback loops: Conduct surveys, interviews and usability tests specifically with HCPs. Gather behavioral data (web analytics, click paths) and iterate the interface. The Discover-Design-Deploy-Measure (DDDM) framework is emerging as a best practice: discover behavioral data and first-party insights, design optimal omnichannel journeys, deploy across integrated platforms, and measure outcomes continuously.

2. Responsive, Mobile-First Design

  • Mobile responsiveness: Ensure the platform works seamlessly on smartphones and tablets. Given that a large share of physicians are mobile-active, the portal interface should adapt fluidly to small screens. Use responsive frameworks or develop a Progressive Web App (PWA) as one case study did, so that key resources are "in HCP's hands whenever and wherever they need it". Testing on actual devices is crucial.

  • Fast load times: Keep pages lightweight (optimize images, scripts) so busy physicians aren't kept waiting. Even short delays can disrupt clinicians juggling patient care.

3. Clear Navigation and Information Architecture

  • Simplify navigation: Design a clean, intuitive menu structure. Place the most important functions (search, latest updates, account settings) prominently. As experts warn, avoid creating a "convoluted maze of menus". A top-level dashboard or home page should highlight key tools, and include a persistent search bar.

  • Logical content taxonomy: Organize content by meaningful categories (e.g. by therapeutic area, guidelines, or patient population). Use clear labels ("Clinical Guidelines", "Drug Info", "Patient Programs" etc.). Consistency across sections reduces cognitive load. If the portal spans multiple brands or countries, implement a multi-site CMS strategy so content updates propagate centrally.

  • Progressive disclosure: Avoid overwhelming new users. Show only core features initially; allow users to "drill down" into more detailed content as needed (e.g. collapsible sections, "learn more" links). This aligns with advice to guard against "overwhelming users with excessive content".

  • Effective search and filtering: Implement a powerful search engine (preferably with autocomplete/AI suggestions) and robust filters (by date, topic, content type). Many HCPs will search keywords. Poor searchability was cited as a major pain point in one pharma portal case. Analytics can identify common search terms and missing content to address.

4. Privacy, Security, and Compliance by Design

  • HIPAA and data protection: Architect the platform to meet applicable HIPAA (US), GDPR (EU), and other privacy requirements. HIPAA’s Security Rule applies to electronic protected health information (ePHI) held by covered entities and business associates. Encryption is an addressable implementation specification: after a risk analysis, implement it when reasonable and appropriate; otherwise document the determination and use a reasonable and appropriate equivalent alternative when required. Protect other HCP personal data under applicable privacy and security obligations. According to the HIPAA Journal's 2025 report, healthcare data breaches cost organizations an average of $7.42 million per incident and $398 per exposed record—making robust security essential. Use risk-based safeguards such as strong authentication (including MFA where appropriate) and role-based access controls. Conduct regular security audits and penetration tests.

  • FDA digital health guidance (January 2026): The FDA issued significant updates to Clinical Decision Support (CDS) software guidance on January 6, 2026. Key changes include: CDS software may remain outside device regulation when it supports HCP decision-making using well-understood clinical data, generates recommendations for HCP review and finalization, and does not analyze complex medical images or signals. The FDA has also loosened its approach to general wellness products, allowing noninvasive wearables that estimate health metrics to claim wellness status if they avoid disease or diagnostic claims. For portals with e-forms, ensure e-signature solutions meet FDA 21 CFR Part 11 requirements, including audit trails that capture who performed an action, what action was performed, and when.

  • Transparent consent: Clearly communicate data use policies to HCPs. Obtain opt-in consent for communications (email, push notifications), respecting evolving privacy laws. A "single privacy policy" covering all channels is best practice for a unified strategy.

  • Demonstrate trust: Include trust signals (e.g. security certificates, compliance badges). The Change Healthcare breach of 2024, which exposed data of nearly 193 million people and cost $2.87 billion, was traced to a lack of multifactor authentication on a Citrix remote-access portal—underscoring the reputational and financial imperative of visible security commitment.

5. Accessibility and Usability

  • HHS Section 504 web and mobile accessibility requirements:Recipients of HHS federal financial assistance must make web content and mobile applications they provide or make available accessible to people with disabilities and conform them to WCAG 2.1 Level AA. Recipients with 15 or more employees must comply by May 11, 2027; recipients with fewer than 15 employees must comply by May 10, 2028. Whether a particular organization or program is covered depends on its receipt of HHS federal financial assistance.

  • WCAG 2.2 readiness: While WCAG 2.1 AA is the regulatory floor, WCAG 2.2 (published October 2023, updated December 2024) is the future standard. WCAG 2.2 adds 9 new success criteria improving accessibility for users with cognitive disabilities, low vision, and mobile users. Consider implementing WCAG 2.2 AA to stay ahead of evolving requirements.

  • Accessibility features: Design so all HCPs can use the site comfortably. This includes adjustable font sizes, high-contrast text, and support for screen readers or translations. The portal should adapt to users' needs, with options like dark mode or simplified layouts for low-vision or color-blind users. For global portals, provide multilingual content or guides.

  • Intuitive language and icons: Use clear, concise wording that matches medical parlance (avoid jargon where possible). Labels should use clinically familiar terms with well-placed icons.

  • Feedback and confirmations: Where appropriate, provide confirmation messages (e.g. for form submissions) and help guidance (tooltips, FAQs). Make error messages clear and actionable.

  • Load test with HCPs: Include busy practitioners in usability testing. Simulate common tasks (finding dosing guidelines, downloading a form) to ensure efficiency.

6. Content Strategy and Value Proposition

  • Keep content fresh and relevant: Regularly update clinical guidelines, trial results, and practice resources. The portal should serve as a "trusted source of specialized information". Assign clear ownership to keep info current. Out-of-date content erodes usage. AI-powered tools can now summarize lengthy clinical documents into digestible insights tailored to each HCP's specialty.

  • Balance educational vs promotional content: Focus on peer-reviewed research, treatment guidelines, and patient case studies, not just product marketing. HCPs continue to value disease education far more than drug pitches. If branding is included, it should be subtle and clearly educational. Amiculum's 2026 predictions emphasize that generative AI and modular content frameworks now support the creation of adaptable messaging that reflects patient needs, literacy levels, and cultural context.

  • Gamification and interactive tools:2025 research shows 98% of physician learners report that gamified education promotes knowledge transfer. Incorporate quizzes, challenges, interactive case studies, calculators, risk stratifiers, or interactive flowcharts that assist clinical work. Short-form educational videos featuring KOLs, live Q&A sessions, and webinars tailored to specialty areas are now preferred engagement formats.

  • Multimedia and snackable content: Use a mix of media (slides, videos, infographics) and "snackable" content blocks to accommodate busy HCPs. Traditional static content is giving way to dynamic, engaging formats. Video, live-streamed events, and interactive case studies are becoming preferred ways for HCPs to consume information. Enable bookmarking or emailing of content for later review.

  • Broader care team engagement: Effective 2026 strategies look beyond physicians to include tailored content for the broader care team—consultation aids for advanced practice providers (APPs), education on drug access and reimbursement for pharmacists, and adherence resources for nurses.

  • Notification and scheduling features: Alert users to new content or events. For time-critical updates (e.g. new safety info), use push notifications or email digests based on user preferences. AI can now automate next-best-action triggers like follow-up resources or scheduling invites.

in 2026, pharma must evolve from providing information to delivering impact, ensuring that trust, relevance, and simplicity guide every interaction.

04

Leveraging Data and Behavioral Insights

Data-driven design is key to effective HCP UX. Collecting and analyzing HCP behavior informs personalization and continuous improvement:

  • Customer Data Platforms (CDPs): Consolidate HCP data (demographics, prescription data, engagement history) into a unified profile. Granular data combined into "connected intelligence" enables mapping each HCP's exact behavior and preferences. Integrating CRM records, online activity, and claim data in a CDP empowers precise personalization. Sales, marketing, and medical teams should operate from a shared view, maximizing every touchpoint.

  • Real-time behavioral analytics: Modern platforms analyze behavior in real-time, adapting content, timing, and channel to fit each HCP's unique preferences. Track user journeys (e.g. most-clicked pages, drop-off points) to reveal pain points and content gaps. AI can now adapt content sequencing dynamically based on individual engagement patterns. A/B testing remains essential for optimizing layouts and wording.

  • Next Best Action (NBA) engines:Leading pharma organizations now deploy AI-powered NBA engines grounded in robust data platforms. These tools provide go-to-market representatives with deep insights into HCP preferences and habits, recommending the most effective actions and communication strategies for each HCP. AI can also test marketing messages for regulatory adherence before release.

  • Predictive modeling and agentic AI: Apply machine learning to predict what content or channel will most engage each HCP. By 2026-27, agentic AI systems will enable pharma brands to deliver context-aware intelligence at unprecedented scale. Industry projections suggest 30-45% productivity gains and 75-85% automation of current pharma-HCP workflows within five years.

  • Reducing fatigue with relevance: To combat HCP "digital fatigue", it's crucial to only send communications that analytics deem relevant. HCPs are more likely to engage with content tailored to their clinical interests, specialty, and current caseload. Personalized content increases open rates, time spent engaging, and conversion to desired actions. Respect opt-outs and frequency limits: irrelevant communications will drive HCPs away.

  • Actionable metrics: Define and track UX KPIs (Table 2). These may include registration/completion rates, time on task, NPS/CSAT scores, and features used. In one portal implementation, an agile engagement campaign increased registrations over 10-fold after optimizing outreach channels. Continuous monitoring guides iterative design improvements.

T.03
MetricDescriptionExample from case studies
Registration Rate% of target HCPs signing up within a periodGrew 10× in 2 weeks after engagement campaign
Unique VisitorsNumber of distinct HCP users45,000 unique HCP visits in one year
Time on Page/TaskAverage duration on key tasks (e.g. form completion)
Form Completion Rate% of initiated forms fully submittedImproved by autosave/auto-fill features
Content Consumption% of target HCPs accessing new resources (e.g. guideline)
Satisfaction ScoreSurvey-based UX satisfaction or NPS
Mobile Access Share% of visits from mobile devices
Table 2: Example UX and engagement metrics for HCP platforms. Case study values from implementers.

In summary, a data-driven approach means treating UX design as an iterative, evidence-based process. Continuous analysis of HCP behavior allows the platform to evolve responsively.

05

Implementation Patterns

The article does not have direct, client-authorized sources for the anonymous implementation outcomes previously presented as case studies. The practical patterns remain useful as design considerations: reduce avoidable re-entry in forms where lawful and appropriate, test responsive experiences on the devices HCPs use, maintain findable and current content, and measure adoption and task completion after launch. Teams should set project-specific targets and evaluate results with their own validated analytics rather than relying on unsourced portal-traffic or registration claims.

Best practice is to **embed compliance into the design process**: treat security, privacy, accessibility, and medical accuracy as integral UX requirements, not afterthoughts.

06

Industry Benchmarks and Regulatory Considerations

  • Engagement Benchmarks: While benchmarks vary, the above cases provide performance indicators (e.g. tens of thousands of visits, registration rates). McKinsey research confirms that omnichannel orchestration generates up to 30% more engagement compared to single-channel campaigns. Achieving high adoption (10× increase) post-launch remains an indicator of optimized, engaging HCP portals. Two-thirds of medtech companies expect online channels to account for more than 20% of revenue by 2025.

  • Data Security & Privacy (2025 Statistics): According to the HIPAA Journal, healthcare data breaches in 2025 averaged 63.5 incidents per month affecting 500 or more individuals, with 275 million records exposed in the US alone. The average cost per breach is $7.42 million and $398 per record—more than triple other industries. Healthcare has topped the list for breach costs for 14 consecutive years. The global average time to identify and contain a breach is 241 days (a 17-day improvement from 2024). The 2024 Change Healthcare breach affecting 193 million people at an estimated cost of $2.87 billion demonstrates the catastrophic potential of security failures.

  • FDA January 2026 Guidance Updates: The FDA's updated Clinical Decision Support (CDS) guidance has removed language that software for time-critical decision-making automatically fails to qualify for enforcement discretion. CDS software may remain outside device regulation when supporting HCP decision-making with well-understood clinical data. The FDA also launched the TEMPO Pilot Program in partnership with CMS to promote access to digital health devices while safeguarding patient safety.

  • Regulatory Content: HCP portals providing medical or promotional content must align with FDA regulations and the PhRMA Code on Interactions with Health Care Professionals. This means ensuring fair balance, using approved terminology, and properly disclosing risks. The FDA's 2025 initiatives emphasize real-world evidence and new approach methodologies to accelerate approvals while maintaining safety standards. In December 2025, the FDA launched the TEMPO pilot program in coordination with CMS, evaluating a risk-based enforcement approach for digital health devices in cardio-kidney-metabolic, musculoskeletal, and behavioral health conditions.

  • Accessibility Standards:HHS Section 504 requirements require recipients of HHS federal financial assistance to conform covered web content and mobile applications to WCAG 2.1 AA. The compliance date is May 11, 2027 for recipients with 15 or more employees and May 10, 2028 for recipients with fewer than 15 employees. OCR enforces Section 504, including through complaint investigations and compliance reviews.

  • Industry Initiatives: Organizations like the Council of Medical Specialty Societies (CMSS), a coalition of more than 50 societies representing nearly 1 million physicians, continue to publish principles for digital HCP communication. The emphasis in 2026 has shifted toward AI governance, ensuring that AI-powered personalization and recommendations remain within compliance boundaries.

In conclusion, HCP engagement platforms sit at the intersection of UX design and regulated content. Best practice is to embed compliance into the design process: treat security, privacy, accessibility, and medical accuracy as integral UX requirements, not afterthoughts.

F.02
Regulatory and security milestones are reshaping HCP platform requirements through 2028
  1. 2023WCAG 2.2 published

    WCAG 2.2 was published in October 2023 and updated in December 2024, offering an updated accessibility standard beyond the WCAG 2.1 AA baseline.

  2. 2024Change Healthcare data breach$2.87 billion

    The 2024 breach exposed 193 million people's data at an estimated cost of $2.87 billion, demonstrating the catastrophic potential of security failures.

  3. 2026FDA CDS guidance update

    FDA issued significant updates to Clinical Decision Support software guidance, clarifying when CDS software remains outside device regulation.

  4. 2027HHS Section 504 deadline (15+ employees)

    Recipients of HHS federal financial assistance with 15 or more employees must conform web and mobile content to WCAG 2.1 AA by May 11, 2027.

  5. 2028HHS Section 504 deadline (under 15 employees)

    Recipients with fewer than 15 employees must comply with WCAG 2.1 AA by May 10, 2028.

07

UX Design Principles (Table)

T.02
Design PrincipleDescriptionSources/Examples (2025-2026)
User-Centric ResearchInvolve HCPs early: use interviews, surveys, and testing to understand workflows and needs.DDDM framework; tailored portals improved engagement
Simplicity & ClarityStreamline navigation; clear labels; minimal clicks to key info.Avoid "labyrinthine" menus; CXQ® scores show clarity drives satisfaction
AI-Powered PersonalizationDeliver content and alerts based on specialty, behavior, and real-time context using AI/ML.NBA engines; 66% of HCPs now use AI tools (2024)
Mobile OptimizationDesign responsive or PWA interfaces for mobile devices (70%+ of HCPs use mobile professionally).eHealthcare Solutions (2025)
Content Relevance & GamificationProvide up-to-date clinical resources, CME, gamified learning; balance disease vs product info.98% say gamified education promotes knowledge transfer
AccessibilityFor recipients of HHS federal financial assistance, covered web content and mobile applications must conform to WCAG 2.1 AA by May 11, 2027 (15+ employees) or May 10, 2028 (fewer than 15 employees); support varied needs.HHS Section 504 requirements; WCAG 2.2 for future-proofing
Security & ComplianceApply risk-based safeguards, including MFA where appropriate. For HIPAA-regulated ePHI, assess encryption as an addressable implementation specification; comply with applicable HIPAA and FDA requirements.Change Healthcare breach ($2.87B) underscores imperative
Analytics & IterationUse real-time analytics and AI to refine UX; implement NBA engines; A/B test layouts.30-45% productivity gains projected with AI analytics
Table 3: Core UX design principles for HCP engagement platforms, updated for 2025-2026.

These principles should guide the design and development of HCP portals, CRMs, and educational platforms. While the implementation details may vary by project, adherence to these fundamentals will help ensure the platform meets HCPs' expectations.

08

Conclusion

As the pharma industry deepens its commitment to digital-first engagement with clinicians, UX design has become a critical enabler—and a regulatory necessity. HCPs demand relevant, streamlined, AI-enhanced, and secure digital experiences that support their clinical work. By following evidence-backed practices — AI-powered personalization, mobile-first responsive design, clear information architecture, robust real-time analytics, and strict compliance with the new HHS accessibility mandate and FDA digital health guidance — IT teams can build platforms that truly engage HCPs.

The 2025-2026 landscape presents both challenges and opportunities: while pharma's CX performance scores have dipped (indicating rising HCP expectations), emerging technologies like agentic AI and Next Best Action engines promise 30-45% productivity gains and dramatically improved personalization. Success comes from continuous iteration: measure HCP behavior (e.g. adoption, satisfaction), iterate the UX using AI-driven insights, and align with evolving regulatory norms—including the WCAG 2.1 AA accessibility requirements under the HHS Section 504 rule for applicable recipients of HHS federal financial assistance, now phased in through 2027-2028.

A well-designed HCP platform not only improves user satisfaction but can lead to measurable business benefits — up to 30% more engagement through omnichannel orchestration, deeper brand trust, and ultimately better patient outcomes through informed clinical decisions.

Sources: Industry reports and research from McKinsey, IQVIA, Forrester, Doceree, eHealthcare Solutions, HIPAA Journal, FDA, HHS, and other experts were used. Citations with links are provided throughout.

Adrien Laurent

Need Expert Guidance on This Topic?

Let's discuss how IntuitionLabs can help you navigate the challenges covered in this article.

I'm Adrien Laurent, Founder & CEO of IntuitionLabs. With 25+ years of experience in enterprise software development, I specialize in creating custom AI solutions for the pharmaceutical and life science industries.

Disclaimer

The information contained in this document is provided for educational and informational purposes only. We make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability, or availability of the information contained herein. Any reliance you place on such information is strictly at your own risk. In no event will IntuitionLabs.ai or its representatives be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from the use of information presented in this document. This document may contain content generated with the assistance of artificial intelligence technologies. AI-generated content may contain errors, omissions, or inaccuracies. Readers are advised to independently verify any critical information before acting upon it. All product names, logos, brands, trademarks, and registered trademarks mentioned in this document are the property of their respective owners. All company, product, and service names used in this document are for identification purposes only. Use of these names, logos, trademarks, and brands does not imply endorsement by the respective trademark holders. IntuitionLabs.ai is an AI software development company specializing in helping life-science companies implement and leverage artificial intelligence solutions. Founded in 2023 by Adrien Laurent and based in San Jose, California. This document does not constitute professional or legal advice. For specific guidance related to your business needs, please consult with appropriate qualified professionals.

Related Articles

Need help with AI?

© 2026 IntuitionLabs. All rights reserved.